Literature DB >> 12186216

Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia.

Peter B Bach1, Sharp F Malak, Joseph Jurcic, Sarah E Gelfand, Janet Eagan, Claudia Little, Kent A Sepkowitz.   

Abstract

We estimated the impact of vancomycin-resistant Enterococcus (VRE) infection on the outcomes of patients with leukemia in a case-control study. Compared with their matched controls (n = 45), cases (n = 23) had 22% greater total charges and shorter survival (P = .04). These findings substantiate the need for aggressive interventions to prevent VRE transmission.

Entities:  

Mesh：

Year:  2002        PMID： 12186216     DOI： 10.1086/502089

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  5 in total

1.  Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.

Authors:  Usha Stiefel; Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 2.  Factors associated with variation in estimates of the cost of resistant infections.

Authors:  Bevin Cohen; Elaine L Larson; Patricia W Stone; Matthew Neidell; Sherry A Glied
Journal:  Med Care       Date:  2010-09       Impact factor: 2.983

3.  Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course.

Authors:  Jin-Hong Yoo; Dong-Gun Lee; Su Mi Choi; Jung-Hyun Choi; Wan-Shik Shin; Myungshin Kim; Dongeun Yong; Kyungwon Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

4.  The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.

Authors:  Tobias Siegfried Kramer; Cornelius Remschmidt; Sven Werner; Michael Behnke; Frank Schwab; Guido Werner; Petra Gastmeier; Rasmus Leistner
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-14       Impact factor: 4.887

5.  Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci.

Authors:  Ahu Kara; İlker Devrim; Nuri Bayram; Nagehan Katipoğlu; Ezgi Kıran; Yeliz Oruç; Nevbahar Demiray; Hurşit Apa; Gamze Gülfidan
Journal:  Braz J Infect Dis       Date:  2014-12-18       Impact factor: 3.257
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.